Pathology tests database

Sample and container requirements

Serum Li Hep plasma

Minimum volume required

2 ml Blood

Special requirements

none

Patient preparation

None

Sample viability

Store at 4oC prior to sending to referral lab

Turnaround time

21 days

Reference range

Suggested target drug conentrations for Adalimumab in the treatment of IBD: Induction/Post induction: Week 4 Adalimumab concentration to target 8-12 ug/mL Maintenance adalimumab concentration to target 8-12 ug/mL

Clinical guidance

Measurement of Adalimumab is a useful tool in the management of patients who fail to respond ( primary failure) or lose response ( secondary failure) to treatment. Monitoring drug levels allows for a personalised approach to drug optimisation by appropriate dose escalation/de-escalation or drug switching/withdrawal. https://www.synnovis.co.uk/our-tests/adalimumab

Notes

Referred test Synnovis